 Pulmonary surveillance bronchoscopy bronchoalveolar lavage high-dose antineoplastic therapy Pulmonary failure major contributor morbidity mortality marrow aplasia high-dose antineoplastic therapy reason pulmonary surveillance program patients high-dose chemotherapy leukemia bone marrow transplantation part program bronchoscopy BAL onset granulocytopenia first patients program evidence pulmonary complications patients aplasia pulmonary failure Forty patients significant abnormalities bronchoscopy treatment patients normal findings x-ray films physical examination pulmonary function testing fever Twenty-seven patients significant abnormal bronchoscopy BAL onset granulocytopenia Thirteen patients additional bronchoscopy patient open lung biopsy Pulmonary surveillance bronchoscopy BAL useful detection pulmonary disease initiation high-dose antineoplastic therapy